BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10383783)

  • 21. Abnormal cutaneous reaction to potassium hydroxide in molluscum contagiosum in children.
    DI Brizzi EV; Russo T; Alfano R; Argenziano G; Piccolo V
    Ital J Dermatol Venerol; 2022 Feb; 157(1):104-105. PubMed ID: 33070569
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
    JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two Cases of Giant Molluscum Contagiosum on the Eyelids of HIV Patients Successfully Treated with Adjuvant Self-Applied Topical 20% Potassium Hydroxide Solution.
    Achdiat PA; Adriyani KM; Pospos AG; Rowawi R; Hindritiani R; Suwarsa O; Gunawan H
    HIV AIDS (Auckl); 2021; 13():993-997. PubMed ID: 34849035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
    Moye V; Cathcart S; Burkhart CN; Morrell DS
    Dermatol Ther; 2013; 26(6):445-51. PubMed ID: 24552407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
    Niazi S; Brabec B; Anschutz L; Willson C; Davidson M; Burnett P
    J Drugs Dermatol; 2021 Jan; 20(1):70-75. PubMed ID: 33400412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical salicylic acid gel as a treatment for molluscum contagiosum in children.
    Leslie KS; Dootson G; Sterling JC
    J Dermatolog Treat; 2005; 16(5-6):336-40. PubMed ID: 16428156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Therapeutic Trial Comparing Modified Autoinoculation, a Novel Approach with Topical Potassium Hydroxide Application in the Treatment of Molluscum Contagiosum.
    Samagani A; Raveendra L; Raju BP
    J Cutan Aesthet Surg; 2022; 15(1):65-70. PubMed ID: 35655641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A potassium hydroxide fountain pen for precise application over molluscum contagiosum lesions.
    Agrawal S; Sharma A; Motiwala M; Dhurat R
    J Am Acad Dermatol; 2023 Jan; 88(1):e7-e8. PubMed ID: 31150708
    [No Abstract]   [Full Text] [Related]  

  • 29. A prospective, open, comparative study of 5% potassium hydroxide solution versus cryotherapy in the treatment of genital warts in men.
    Camargo CL; Belda Junior W; Fagundes LJ; Romiti R
    An Bras Dermatol; 2014; 89(2):236-40. PubMed ID: 24770498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anetoderma in molluscum contagiosum treated with 10% potassium hydroxide.
    Verma SB
    Australas J Dermatol; 2021 Aug; 62(3):e475-e476. PubMed ID: 34129233
    [No Abstract]   [Full Text] [Related]  

  • 31. Verrucous plaque-like lesion with progressive growth in the scalp of a 3-month-old infant.
    Prieto-Torres L; Sanchez-Bernal J; Felipo F; Ara-Martín M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(6):384-385. PubMed ID: 28284684
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of molluscum contagiosum with an East Indian sandalwood oil product.
    Haque M; Coury DL
    J Dermatolog Treat; 2018 Aug; 29(5):531-533. PubMed ID: 29103323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical 20% KOH--an effective therapeutic modality for moluscum contagiosum in children.
    Mahajan BB; Pall A; Gupta RR
    Indian J Dermatol Venereol Leprol; 2003; 69(2):175-7. PubMed ID: 17642872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of molluscum contagiosum with intralesional immunotherapy by measles, mumps, and rubella vaccine: a report of two cases.
    Na CH; Kim DJ; Kim MS; Kim JK; Shin BS
    Dermatol Ther; 2014; 27(6):373-6. PubMed ID: 25053017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of molluscum contagiosum: a brief review and discussion of a case successfully treated with adapelene.
    Scheinfeld N
    Dermatol Online J; 2007 Jul; 13(3):15. PubMed ID: 18328209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study.
    Syed TA; Lundin S; Ahmad M
    Dermatology; 1994; 189(1):65-8. PubMed ID: 8003791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molluscum contagiosum: recent advances in pathogenic mechanisms, and new therapies.
    Smith KJ; Skelton H
    Am J Clin Dermatol; 2002; 3(8):535-45. PubMed ID: 12358555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open, randomized, comparative clinical and histological study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum.
    Seo SH; Chin HW; Jeong DW; Sung HW
    Ann Dermatol; 2010 May; 22(2):156-62. PubMed ID: 20548905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood skin and soft tissue infections: new discoveries and guidelines regarding the management of bacterial soft tissue infections, molluscum contagiosum, and warts.
    Rush J; Dinulos JG
    Curr Opin Pediatr; 2016 Apr; 28(2):250-7. PubMed ID: 26900921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children.
    Arican O
    Pediatr Int; 2006 Aug; 48(4):403-5. PubMed ID: 16911087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.